Related Experiment Video
Updated: May 5, 2026
Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
A multi-biomarker panel for non-invasive diagnosis, risk stratification, subtype identification, and therapeutic
Kanglong Zhang1, Yiming Gan1, Yihua Chen1
1Department of Infectious Diseases, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, 518036, Guangdong Province, China.
Background:
Nonalcoholic fatty liver disease (NAFLD) lacks reliable non-invasive diagnostic tools and effective therapeutic targets. This study aimed to identify serum biomarkers for diagnosis, risk stratification, and therapeutic targeting.
Materials And Methods:
Inflammation- and NET-related differentially expressed genes (INRDEGs) were screened from GEO datasets. LASSO/SVM regression constructed a diagnostic model, validated via ROC/calibration/decision curve analyses. Immune infiltration (CIBERSORT/ssGSEA), consensus clustering, and interaction networks (miRNA/TF/drug) were employed. Hub genes were validated in diet-induced NASH mice.
Results:
TNF, IL6, CCL5, and SPP1 were identified as key biomarkers. The diagnostic model achieved high accuracy (AUC = 0.803) and enabled risk stratification: TNF, SPP1, and CCL5 marked high-risk patients, while IL6 dominated low-risk subgroups. Two NAFLD subtypes with distinct immune profile were classified. Key biomarkers were identified as potential therapeutic targets. Regulatory networks predicted repurposable drugs. Animal experiments confirmed elevated serum levels of these genes in NASH mice (p < 0.001).
Conclusions:
This study establishesed TNF, IL6, CCL5, and SPP1 as a multi-functional biomarker panel for NAFLD, enabling non-invasive diagnosis, risk stratification, subtype classification, and target-specific therapy. These findings provide new insights for the management of NAFLD and a feasible theoretical basis for clinical translation.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
05:37Author Spotlight: A Non-Invasive Tool to Assess and Differentiate Fat Patterns in Liver Using 3D Dixon MRI
Published on: October 20, 2023
